Abstract: A sound attenuation system can include a first end that can include a shaft and a flange, the flange can be coupled to the shaft, and a second end that can include a filter stem and a cap. The filter stem can have a hole. The cap can have a first position in which the cap occludes the hole and can have a second position in which the cap is clear of the hole.
Abstract: An ice maker includes an ice making unit comprising an evaporator connected to a refrigeration system, an ice holding bin, a sump, a pump, a drain valve, an ozonated water source, and a controller. The controller activates the ozonated water source supplying a first volume of ozonated water to the sump, thereafter activates the pump to circulate the first volume of ozonated water from the sump to the ice making unit, once a predetermined sterilization time has been reached, the controller turns off the pump and drains the first volume of ozonated water from the sump. The controller initiates an ice making mode, and activates the ozonated water source to supply a second volume of ozonated water to the sump, thereafter activates the pump to circulate the second volume of ozonated water from the sump to the ice making unit forming ozonated ice on the evaporator, and initiates an ice harvest mode to remove the ozonated ice from the evaporator and delivers it to the ice holding bin.
Abstract: Compositions and methods are disclosed herein for producing one or more immunoglobulins in an isolated cytotoxic B lymphocyte cell line. An isolated cell line includes an isolated B lymphocyte cell line capable of expressing at least one exogenously incorporated membrane immunoglobulin reactive to a first antigen and at least one endogenous secreted immunoglobulin reactive to a second antigen, and further capable of expressing at least one exogenously incorporated recombinant B cell receptor that signals for expression of cytotoxic effector molecules.
Type:
Grant
Filed:
January 24, 2019
Date of Patent:
November 23, 2021
Assignee:
THE INVENTION SCIENCE FUND II, LLC
Inventors:
Roderick A. Hyde, Wayne R. Kindsvogel, Gary L. McKnight
Abstract: A wind instrument neck receiver tension mechanism is provided having a body, a retaining ridge, and a tension band. The body has a lower body end and a upper body end. The upper body end defines a thin collar seating wall, which has at least one notch. In some embodiments there are four equally sized notches. A retaining ridge extends from the thin collar seating wall and a tension band having an adjustable compression ring, the adjustable compression ring disposed between said thin collar seating wall and the retaining ridge. When adjusted to a first position, the compression ring compresses the thin collar seating wall in a uniform compression around a circumference of a neck receiver of a wind instrument.
Abstract: A collapsible artificial tree is provided. The collapsible artificial tree includes one or more branch assemblies extending from an elongated trunk, wherein each branch assembly can transition between an extended configuration and a retracted configuration. Each branch assembly includes a scissor arm having a plurality of beam members pivotally linked to one another, wherein the scissor arm is connected to a first and second collar. The first collar and second collar are disposed in a stacked orientation along the trunk, wherein the second collar is slidably engaged with the trunk. As the second collar slides towards the first collar, the branch assembly extends outward from the trunk to the extended configuration. In the retracted configuration, the plurality of beam members is oriented generally vertical to the elongated trunk. These configurations provide for compact storage when not in use and mimicking of a tree structure when in the extended configuration.
Abstract: Provided herein are encapsulated liposomes comprising a lipid bilayer, a first polyethylene glycol (PEG) corona, a targeting molecule and a second PEG corona. The second, encapsulating PEG corona can be reversibly linked to the first PEG corona. Also provided are pharmaceutical compositions comprising the encapsulated liposomes and methods of treating a subject with a disease characterized by production of reactive oxygen species (ROS) with the compositions. Also provided are methods of making the encapsulated liposomes disclosed herein.
Type:
Grant
Filed:
November 21, 2019
Date of Patent:
November 23, 2021
Assignee:
VERILY LIFE SCIENCES LLC
Inventors:
Kimberly Kam, Zhan Wang, Stephen Morton, Nicole Peck
Abstract: Methods and systems of monitoring and controlling a longwall mining system. One system includes a shearer including a cutter drum and a sensor mounted to the shearer. The system also includes an electronic controller including a processor and a memory. The electronic controller is configured to receive an impact event indication associated with an impact event of the cutter drum, the impact event indication based on vibration data collected by the sensor. The electronic controller is also configured to retrieve additional data associated with the impact event indication and link the additional data with the vibration data of the impact event indication. The electronic controller is also configured to create and store an impact event record including the vibration data and the additional data. The electronic controller is configured to, in response to receiving a maintenance request, export the impact event record for display.
Abstract: Systems, devices, and methods may control total particulate matter (TPM) production based on air flow rate and TPM density. TPM density is a TPM production rate per flow rate of gas through an aerosol-generating device. The systems, devices, and methods may measure, or sample, air flow during a puff or draw on an aerosol-generating device. The aerosol-generating device may, in turn, adjust the production of the TPM based on the measured air flow rate and a selected, or desired, TPM density, which may be pre-set in the device and/or subsequently set as desired.
Abstract: A composition for use in the treatment of rosacea includes a multi-kinase inhibitor that inhibits both a Vascular Endothelial Growth Factor Receptor and a Fibroblast Growth Factor Receptor. A method for treating rosacea for a patient includes inhibiting a Vascular Endothelial Growth Factor Receptor of the patient; and inhibiting a Fibroblast Growth Factor Receptor of the patient.
Abstract: Systems and methods for data communication over a plurality of data paths are disclosed. Messages between a first node and a second node may be transmitted, wherein some of the messages are transmitted over a first data path using a first communication protocol, and some of the messages are transmitted over a second data path using a second communication protocol. A determination may be made that the first data path is altering a flow of messages due to the messages being transmitted using the first communication protocol and a number of messages sent over the different data paths adjusted in response, wherein adjusting comprises decreasing a number of the messages transmitted over the first data path and increasing a number of messages transmitted over the second data path, wherein altering the flow of messages is performed automatically under control of an expert system.
Type:
Grant
Filed:
December 28, 2018
Date of Patent:
November 23, 2021
Assignee:
Strong Force IoT Portfolio 2016, LLC
Inventors:
Charles Howard Cella, Gerald William Duffy, Jr., Jeffrey P. McGuckin, Mehul Desai